Omeros (OMER): OMS721 For Kidney Diseases Looks Exciting - Wedbush
Tweet Send to a Friend
Wedbush analyst, Liana Moussatos, reiterated her Outperform rating on shares of Omeros Corp. (NASDAQ: OMER) after initial results for OMS721 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE